FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023119319> ?p ?o ?g. }

• W2023119319 endingPage "22" @default.
• W2023119319 startingPage "113" @default.
• W2023119319 abstract "Interleukin (IL)-12 can enhance the development of effective immune responses against tumors as well as against certain infectious agents. It is therefore a potential candidate for therapeutic use in cancer therapy and in design of vaccines against several infectious diseases.The authors have established a specific cytotoxic T-cell line (TIL-Heu) from lymphocytes infiltrating a human large cell carcinoma of the lung (LCC). In the current report, the authors have investigated the in vivo effect of recombinant human IL-12 (rhIL-12) on the adoptive transfer of TIL-Heu cells in autologous tumor (Heu-n) engrafted into severe combined immunodeficiency disease-nonobese diabetic (SCID-NOD) mice.Initial in vitro experiments indicated that rhIL-12 increased the cytotoxic potential of TIL-Heu cells in a dose-dependent manner. Heu-n tumors transplanted into SCID-NOD mice were injected with TIL-Heu cells, resulting in a significant tumor growth inhibition. When low doses of rhIL-12 were injected intratumorally after TIL-Heu transfer, a clear increase in tumor growth suppression was observed. Surprisingly, higher doses of rhIL-12 had no effect on cytotoxic T lymphocyte (CTL)-induced prevention of tumor growth. Further in vitro experiments revealed an inhibition of tumor cell lysis after incubation with supernatant of TIL-Heu cells stimulated with high doses of rhIL-12, strongly suggesting that an immunosuppressive factor secreted by the high dose IL-12-stimulated CTL may be responsible for the tumor escape observed in vivo.The authors' data indicate that IL-10 may play a critical role in the lack of effect of high dose IL-12, by mediating tumor cell resistance to CTL killing. Therefore, understanding the cross-talk between immunoregulatory and immunosuppressive cytokines ultimately may provide new approaches to improve cytokine-mediated cancer immunotherapy." @default.
• W2023119319 created "2016-06-24" @default.
• W2023119319 creator A5001290459 @default.
• W2023119319 creator A5006665950 @default.
• W2023119319 creator A5019890773 @default.
• W2023119319 creator A5029144785 @default.
• W2023119319 creator A5045530749 @default.
• W2023119319 creator A5061495123 @default.
• W2023119319 creator A5076945656 @default.
• W2023119319 creator A5087915387 @default.
• W2023119319 date "2001-01-01" @default.
• W2023119319 modified "2023-10-18" @default.
• W2023119319 title "Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction." @default.
• W2023119319 cites W1598996496 @default.
• W2023119319 cites W1966333025 @default.
• W2023119319 cites W1979657237 @default.
• W2023119319 cites W2015763364 @default.
• W2023119319 cites W2020848957 @default.
• W2023119319 cites W2038639621 @default.
• W2023119319 cites W2057388798 @default.
• W2023119319 cites W2065533784 @default.
• W2023119319 cites W2088645772 @default.
• W2023119319 cites W2092768308 @default.
• W2023119319 cites W2103636788 @default.
• W2023119319 cites W2113687012 @default.
• W2023119319 cites W2151707711 @default.
• W2023119319 cites W2151768520 @default.
• W2023119319 cites W2170076907 @default.
• W2023119319 cites W2321275406 @default.
• W2023119319 cites W249403745 @default.
• W2023119319 cites W4248044859 @default.
• W2023119319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11148567" @default.
• W2023119319 hasPublicationYear "2001" @default.
• W2023119319 type Work @default.
• W2023119319 sameAs 2023119319 @default.
• W2023119319 citedByCount "9" @default.
• W2023119319 countsByYear W20231193192016 @default.
• W2023119319 countsByYear W20231193192023 @default.
• W2023119319 crossrefType "journal-article" @default.
• W2023119319 hasAuthorship W2023119319A5001290459 @default.
• W2023119319 hasAuthorship W2023119319A5006665950 @default.
• W2023119319 hasAuthorship W2023119319A5019890773 @default.
• W2023119319 hasAuthorship W2023119319A5029144785 @default.
• W2023119319 hasAuthorship W2023119319A5045530749 @default.
• W2023119319 hasAuthorship W2023119319A5061495123 @default.
• W2023119319 hasAuthorship W2023119319A5076945656 @default.
• W2023119319 hasAuthorship W2023119319A5087915387 @default.
• W2023119319 hasConcept C147969180 @default.
• W2023119319 hasConcept C150903083 @default.
• W2023119319 hasConcept C154317977 @default.
• W2023119319 hasConcept C167672396 @default.
• W2023119319 hasConcept C202751555 @default.
• W2023119319 hasConcept C203014093 @default.
• W2023119319 hasConcept C207001950 @default.
• W2023119319 hasConcept C2776090121 @default.
• W2023119319 hasConcept C2777371288 @default.
• W2023119319 hasConcept C2777701055 @default.
• W2023119319 hasConcept C2779468541 @default.
• W2023119319 hasConcept C502942594 @default.
• W2023119319 hasConcept C55493867 @default.
• W2023119319 hasConcept C55851684 @default.
• W2023119319 hasConcept C71924100 @default.
• W2023119319 hasConcept C86803240 @default.
• W2023119319 hasConcept C8891405 @default.
• W2023119319 hasConcept C90375314 @default.
• W2023119319 hasConceptScore W2023119319C147969180 @default.
• W2023119319 hasConceptScore W2023119319C150903083 @default.
• W2023119319 hasConceptScore W2023119319C154317977 @default.
• W2023119319 hasConceptScore W2023119319C167672396 @default.
• W2023119319 hasConceptScore W2023119319C202751555 @default.
• W2023119319 hasConceptScore W2023119319C203014093 @default.
• W2023119319 hasConceptScore W2023119319C207001950 @default.
• W2023119319 hasConceptScore W2023119319C2776090121 @default.
• W2023119319 hasConceptScore W2023119319C2777371288 @default.
• W2023119319 hasConceptScore W2023119319C2777701055 @default.
• W2023119319 hasConceptScore W2023119319C2779468541 @default.
• W2023119319 hasConceptScore W2023119319C502942594 @default.
• W2023119319 hasConceptScore W2023119319C55493867 @default.
• W2023119319 hasConceptScore W2023119319C55851684 @default.
• W2023119319 hasConceptScore W2023119319C71924100 @default.
• W2023119319 hasConceptScore W2023119319C86803240 @default.
• W2023119319 hasConceptScore W2023119319C8891405 @default.
• W2023119319 hasConceptScore W2023119319C90375314 @default.
• W2023119319 hasIssue "1" @default.
• W2023119319 hasLocation W20231193191 @default.
• W2023119319 hasOpenAccess W2023119319 @default.
• W2023119319 hasPrimaryLocation W20231193191 @default.
• W2023119319 hasRelatedWork W1930066950 @default.
• W2023119319 hasRelatedWork W1963624862 @default.
• W2023119319 hasRelatedWork W1988241479 @default.
• W2023119319 hasRelatedWork W2023119319 @default.
• W2023119319 hasRelatedWork W2081183022 @default.
• W2023119319 hasRelatedWork W2102852505 @default.
• W2023119319 hasRelatedWork W2127094135 @default.
• W2023119319 hasRelatedWork W2161432319 @default.
• W2023119319 hasRelatedWork W289715417 @default.
• W2023119319 hasRelatedWork W97592396 @default.
• W2023119319 hasVolume "91" @default.

• next